Back to search

Article

Single-base precision design of CRISPR-Cas13b enables systematic silencing of oncogenic fusions

2022-06-23

Abstract excerpt

<h4>ABSTRACT</h4> Precision oncology programs can rapidly identify oncogenic gene fusions in individual patients 1–3 . However, despite their established oncogenic status, the vast majority of gene fusions remain ‘ undruggable ’ due to the lack of specific inhibitory molecules 4, 5 . Here, we establish Psp Cas13b, a poorly characterized programmable RNA nuclease, as a versatile tool to silence various oncogen...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
332fbd9f-0dc9-5de2-9c29-7bf19c17a4cc
DOI
10.1101/2022.06.22.497105
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Single-base precision design of CRISPR-Cas13b enables systematic silencing of oncogenic fusionsDOI 10.1101/2022.06.22.497105
Select a neighboring publication to make it the new centre.